title: Present status and future perspectives on the development of bioartificial kidneys for the treatment of acute and chronic renal failure patients.
abstract: A bioartificial renal tubule device (BTD) consisting of a hollow-fiber module and human proximal tubular epithelial cells has been completed technically by Humes and colleagues and a few other groups. Humes and colleagues developed BTD, treated acute kidney injury patients with multiorgan failure by continuous hemofiltration (CHF) in conjunction with BTD, and reported a significantly higher survival rate than that by CHF with BTD without cells in the Food and Drug Administration phase IIa trial. However, BTD has never been approved by the US Government, as the CHF+BTD treatment did not show a significant difference from the control group in the phase IIb trial. Human proximal tubular epithelial cells were confirmed to be overgrown on artificial membrane, which resulted in the inhibition of active transports and the metabolism of essential substances. Function of the BTD could be maintained in a U0126-contained medium, even if the BTD had to have been waited by a new acute kidney injury patient for several weeks. For wearable kidneys, heparin-covalently bound membrane or methacryloyloxyethyl phosphorylcholine (MPC) polymer-coated membranes are candidates for antithrombogenic hemofilters, while endothelial progenitor cells from a cord blood, CD133(+) cells-attached hemofilter in which the permeability of the cells was enhanced by the enlarged diameter of fenestrae by treating with cytochalasin B are another candidate. The MPC blend membrane containing 1% of the MPC polymer in polysulfone was developed as a BTD module. MPC was 7 times larger at the sponge layer than at the skin layer of the membrane, resulting in hemocompatibility at the sponge layer and cytocompatibility at the skin layer.
authors.affiliation: Department of Medicine, Division of Nephrology and Metabolism, Tokai University School of Medicine, Isehara, Japan. asait@is.icc.u-tokai.ac.jp
authors.forename: Akira
authors.initials: A
authors.lastname: Saito
authors.forename: Kaichiro
authors.initials: K
authors.lastname: Sawada
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fujimura
mesh_terms: D058186:Acute Kidney Injury / Q000628:therapy; D000818:Animals; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D007688:Kidneys, Artificial; D006435:Renal Dialysis / Q000295:instrumentation